FAS Ligand

FAS Ligand Overview

English NameSoluble Fas ligandApproved Drugs0
Drugs in Clinical Trials3Target SynonymCD95L,Fas ligand,SPA,FASLG,Soluble Fas ligand,sFasL,Receptor-binding FasL ectodomain,FasL ICD,TNFSF6,Apoptosis antigen ligand,Tumor necrosis factor ligand superfamily member 6,APL,CD178,Fas Ligand (TNF Superfamily, Member 6),Fas Antigen Ligand,CD95 Ligand,CD95-L,APTL,Mutant Tumor Necrosis Factor Family Member 6,Apoptosis (APO-1) Antigen Ligand 1,CD178 Antigen,ALPS1B,TNLG1A,FasL,Fas Ligand Protein,SPPL2A-processed FasL form,APT1LG1,Tumor Necrosis Factor (Ligand) Superfamily, Member 6,Tumor Necrosis Factor Ligand 1A
Highest Development StagePhase 2 Clinical
English NameSoluble Fas ligand
Target SynonymCD95L,Fas ligand,SPA,FASLG,Soluble Fas ligand,sFasL,Receptor-binding FasL ectodomain,FasL ICD,TNFSF6,Apoptosis antigen ligand,Tumor necrosis factor ligand superfamily member 6,APL,CD178,Fas Ligand (TNF Superfamily, Member 6),Fas Antigen Ligand,CD95 Ligand,CD95-L,APTL,Mutant Tumor Necrosis Factor Family Member 6,Apoptosis (APO-1) Antigen Ligand 1,CD178 Antigen,ALPS1B,TNLG1A,FasL,Fas Ligand Protein,SPPL2A-processed FasL form,APT1LG1,Tumor Necrosis Factor (Ligand) Superfamily, Member 6,Tumor Necrosis Factor Ligand 1A
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 2 Clinical

FAS Ligand Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (1)Cynomolgus / Rhesus macaque (1)

  • Tag

    His Tag (2)

  • Conjugate

    Unconjugated (2)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
FAL-H5241
Human
HEK293
Human Fas Ligand / TNFSF6 Protein, His Tag, premium grade
FAL-H5246
Cynomolgus / Rhesus macaque
HEK293
Cynomolgus / Rhesus macaque Fas Ligand / TNFSF6 Protein, His Tag, premium grade
Total: 2
  • 1

FAS Ligand Synonyms

FAS Ligand

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
AsunerceptCAN-008; APG-101Phase 2 ClinicalApogenix GmbhCoronavirus Disease 2019 (COVID-19); Eye Diseases; Glioblastoma; Hematologic Neoplasms; Myelodysplastic Syndromes; Skin Diseases; Solid tumours
Details
XelafaslatideONL-1204Phase 2 ClinicalOnl TherapeuticsGeographic Atrophy; Glaucoma, Open-Angle; Macular Degeneration; Retinal Detachment
Details
M3T01M3T01Phase 1 ClinicalProvidence Health & ServicesSolid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland